Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Krystal Biotech, Inc.    KRYS

KRYSTAL BIOTECH, INC.

(KRYS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/23/2020 03/24/2020 03/25/2020 03/26/2020 03/27/2020 Date
36.02(c) 38.88(c) 37.7(c) 40.5(c) 38.5(c) Last
118 788 134 651 115 438 155 214 84 716 Volume
-7.24% +7.94% -3.03% +7.43% -4.94% Change
More quotes
Financials (USD)
Sales 2020 -
EBIT 2020 -49,0 M
Net income 2020 -48,3 M
Finance 2020 253 M
Yield 2020 -
Sales 2021 15,9 M
EBIT 2021 -54,2 M
Net income 2021 -56,8 M
Finance 2021 205 M
Yield 2021 -
P/E ratio 2020 -14,8x
P/E ratio 2021 -13,3x
EV / Sales2020 -
EV / Sales2021 29,1x
Capitalization 668 M
More Financials
Company
Krystal Biotech, Inc. is a gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending... 
More about the company
Surperformance© ratings of Krystal Biotech, Inc.
Trading Rating : Investor Rating : -
More Ratings
Latest news on KRYSTAL BIOTECH, INC.
03/10KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Financial..
AQ
03/10KRYSTAL BIOTECH : Management's Discussion and Analysis of Financial Condition an..
AQ
03/10Krystal Biotech Reports 2019 Financial Results and Business Progress
GL
02/25KRYSTAL BIOTECH, INC. : Change in Directors or Principal Officers, Financial Sta..
AQ
02/25Krystal Biotech Announces Change in Financial Leadership
GL
02/21Krystal Biotech to Present at the Cowen 40th Annual Healthcare Conference
GL
01/24KRYSTAL BIOTECH : Summary ToggleKrystal Biotech Breaks Ground On Second Commerci..
PU
01/24Krystal Biotech Breaks Ground On Second Commercial Gene Therapy Manufacturing..
GL
01/21Krystal Biotech Appoints Jennifer Chien as Chief Commercial Officer
GL
2019Pfizer, Novartis lead $2 billion spending spree on gene therapy production
RE
2019Krystal Biotech to Present at the Piper Jaffray 31st Annual Healthcare Confer..
GL
2019KRYSTAL BIOTECH : Results of Operations and Financial Condition, Financial State..
AQ
2019KRYSTAL BIOTECH : Summary ToggleKrystal Biotech Reports Third Quarter 2019 Finan..
PU
2019KRYSTAL BIOTECH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
2019KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhib..
AQ
More news
News in other languages on KRYSTAL BIOTECH, INC.

- No features available -

More news
Chart KRYSTAL BIOTECH, INC.
Duration : Period :
Krystal Biotech, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KRYSTAL BIOTECH, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Average target price 75,33  $
Last Close Price 38,50  $
Spread / Highest target 160%
Spread / Average Target 95,7%
Spread / Lowest Target 55,8%
EPS Revisions
Managers
NameTitle
Krish S. Krishnan Chairman, President & Chief Executive Officer
Suma M. Krishnan Chief Operating Officer & Director
Dan S. Janney Independent Director
Dino A. Rossi Independent Director
Rockford Douglas Norby Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
KRYSTAL BIOTECH, INC.-30.48%668
GILEAD SCIENCES12.11%92 991
VERTEX PHARMACEUTICALS-0.78%58 203
REGENERON PHARMACEUTICALS19.72%49 236
WUXI APPTEC CO., LTD.5.36%22 502
GENMAB A/S-8.03%13 112